Response to Evans et al
- PMID: 30563985
- DOI: 10.1038/s41436-018-0400-2
Response to Evans et al
Comment on
-
MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer.Genet Med. 2018 Oct;20(10):1167-1174. doi: 10.1038/gim.2017.254. Epub 2018 Jan 18. Genet Med. 2018. PMID: 29345684 Free PMC article.
-
Are women with pathogenic variants in PMS2 and MSH6 really at high lifetime risk of breast cancer?Genet Med. 2019 Aug;21(8):1878-1879. doi: 10.1038/s41436-018-0401-1. Epub 2018 Dec 14. Genet Med. 2019. PMID: 30631111 No abstract available.
References
-
- Roberts ME, Jackson SA, Susswein LR, et al. MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer. Genet Med. 2018;20:1167–1174. - DOI
-
- Roberts ME, Zeinomar N, Solomon BD, Terry MB, Chung WK. Response to ten Broeke et al. Genet Med. 2018 May 24; doi:10.1038/s41436-018-0031-7 [Epub ahead of print].
-
- Evans DG, Woodward ER, Lalloo F, et al. Are women with pathogenic variants in PMS2 and MSH6 really at high lifetime risk of breast cancer? Genet Med. 2018 December 14; https://doi.org/10.1038/s41436-018-0401-1 . [Epub ahead of print]. - DOI
-
- Couch FJ, Shimelis H, Hu C, et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 2017;3:1190–1196. - DOI
-
- ten Broeke SW, Brohet RM, Tops CM, et al. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk. J Clin Oncol. 2015;33:319–325. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases